Cargando…
Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
International Society of Nephrology. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055946/ https://www.ncbi.nlm.nih.gov/pubmed/33887317 http://dx.doi.org/10.1016/j.kint.2021.04.009 |
| _version_ | 1783680547530211328 |
|---|---|
| author | Attias, Philippe Sakhi, Hamza Rieu, Philippe Soorkia, Arvish Assayag, David Bouhroum, Sabrina Nizard, Patrice El Karoui, Khalil |
| author_facet | Attias, Philippe Sakhi, Hamza Rieu, Philippe Soorkia, Arvish Assayag, David Bouhroum, Sabrina Nizard, Patrice El Karoui, Khalil |
| author_sort | Attias, Philippe |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8055946 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | International Society of Nephrology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80559462021-04-20 Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients Attias, Philippe Sakhi, Hamza Rieu, Philippe Soorkia, Arvish Assayag, David Bouhroum, Sabrina Nizard, Patrice El Karoui, Khalil Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2021-06 2021-04-20 /pmc/articles/PMC8055946/ /pubmed/33887317 http://dx.doi.org/10.1016/j.kint.2021.04.009 Text en © 2021 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Attias, Philippe Sakhi, Hamza Rieu, Philippe Soorkia, Arvish Assayag, David Bouhroum, Sabrina Nizard, Patrice El Karoui, Khalil Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients |
| title | Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients |
| title_full | Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients |
| title_fullStr | Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients |
| title_full_unstemmed | Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients |
| title_short | Antibody response to the BNT162b2 vaccine in maintenance hemodialysis patients |
| title_sort | antibody response to the bnt162b2 vaccine in maintenance hemodialysis patients |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055946/ https://www.ncbi.nlm.nih.gov/pubmed/33887317 http://dx.doi.org/10.1016/j.kint.2021.04.009 |
| work_keys_str_mv | AT attiasphilippe antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients AT sakhihamza antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients AT rieuphilippe antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients AT soorkiaarvish antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients AT assayagdavid antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients AT bouhroumsabrina antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients AT nizardpatrice antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients AT elkarouikhalil antibodyresponsetothebnt162b2vaccineinmaintenancehemodialysispatients |